To examine the effect of SPOP mutations on Caprin1 protein levels in prostate cancer specimens from patients, we analyzed Caprin1 protein levels by immunohistochemistry (IHC) methods in a cohort for which a total of 131 primary prostate tumor samples were available (Additional file 2: Table S2). This evidence concerns the gene SPOP and prostate cancer.